Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumors.

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumors. / Boyle, Jenny L; Haupt, Helen M; Stern, Jere B; Multhaupt, Hinke A B.

In: Archives of Pathology & Laboratory Medicine, Vol. 126, No. 7, 2002, p. 816-22.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Boyle, JL, Haupt, HM, Stern, JB & Multhaupt, HAB 2002, 'Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumors.', Archives of Pathology & Laboratory Medicine, vol. 126, no. 7, pp. 816-22.

APA

Boyle, J. L., Haupt, H. M., Stern, J. B., & Multhaupt, H. A. B. (2002). Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumors. Archives of Pathology & Laboratory Medicine, 126(7), 816-22.

Vancouver

Boyle JL, Haupt HM, Stern JB, Multhaupt HAB. Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumors. Archives of Pathology & Laboratory Medicine. 2002;126(7):816-22.

Author

Boyle, Jenny L ; Haupt, Helen M ; Stern, Jere B ; Multhaupt, Hinke A B. / Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumors. In: Archives of Pathology & Laboratory Medicine. 2002 ; Vol. 126, No. 7. pp. 816-22.

Bibtex

@article{f2640120acd311ddb538000ea68e967b,
title = "Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumors.",
abstract = "CONTEXT: Pathologists may encounter problems in the differential diagnosis of malignant melanoma, spindle and epithelioid neoplasms of peripheral nerves, and fibrohistiocytic tumors. Tyrosinase has been demonstrated to be a sensitive marker for melanoma. OBJECTIVE: To determine the specificity of tyrosinase expression in the differential diagnosis of melanoma, desmoplastic melanoma, and peripheral nerve sheath tumors. DESIGN: Immunoreactivity for tyrosinase, HMB-45 (anti-gp100 protein), S100 protein, CD34, and vimentin was studied in 70 tumors, including 15 melanomas (5 desmoplastic, 4 amelanotic, 6 melanotic), 13 malignant peripheral nerve sheath tumors; 10 schwannomas (1 pigmented), 12 neurofibromas (4 pigmented), and 20 fibrohistiocytic tumors (10 dermatofibrosarcoma protuberans and 10 dermatofibromas). Microwave-based antigen retrieval was performed in 10mM citrate buffer, pH 6.0, for 20 minutes at 121 degrees C. RESULTS: All melanomas demonstrated positive immunostaining for tyrosinase, HMB-45, and S100 protein. Immunoreactivity for HMB-45 was generally stronger than that for tyrosinase in amelanotic lesions and significantly stronger in 1 of the desmoplastic lesions. The 4 pigmented neurofibromas were focally positive for tyrosinase, but did not stain for HMB-45. The pigmented schwannoma was focally positive for both tyrosinase and HMB-45. The malignant peripheral nerve sheath tumors, dermatofibrosarcoma protuberans, and dermatofibromas were nonreactive for tyrosinase and HMB-45. CONCLUSIONS: Our results support the sensitivity of tyrosinase expression and demonstrate the relative specificity of tyrosinase as a marker for melanocytic lesions, including desmoplastic melanoma, although pigmented peripheral nerve tumors may demonstrate focal positive staining. Immunoreactivity for tyrosinase and HMB-45 may have been enhanced by the microwave-based antigen-retrieval technique used in this study.",
author = "Boyle, {Jenny L} and Haupt, {Helen M} and Stern, {Jere B} and Multhaupt, {Hinke A B}",
note = "Keywords: Antigens, CD34; Dermatofibrosarcoma; Diagnosis, Differential; Humans; Immunoenzyme Techniques; Melanoma; Monophenol Monooxygenase; Neoplasm Proteins; Nerve Sheath Neoplasms; S100 Proteins; Skin Neoplasms; Tumor Markers, Biological; Vimentin",
year = "2002",
language = "English",
volume = "126",
pages = "816--22",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "7",

}

RIS

TY - JOUR

T1 - Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumors.

AU - Boyle, Jenny L

AU - Haupt, Helen M

AU - Stern, Jere B

AU - Multhaupt, Hinke A B

N1 - Keywords: Antigens, CD34; Dermatofibrosarcoma; Diagnosis, Differential; Humans; Immunoenzyme Techniques; Melanoma; Monophenol Monooxygenase; Neoplasm Proteins; Nerve Sheath Neoplasms; S100 Proteins; Skin Neoplasms; Tumor Markers, Biological; Vimentin

PY - 2002

Y1 - 2002

N2 - CONTEXT: Pathologists may encounter problems in the differential diagnosis of malignant melanoma, spindle and epithelioid neoplasms of peripheral nerves, and fibrohistiocytic tumors. Tyrosinase has been demonstrated to be a sensitive marker for melanoma. OBJECTIVE: To determine the specificity of tyrosinase expression in the differential diagnosis of melanoma, desmoplastic melanoma, and peripheral nerve sheath tumors. DESIGN: Immunoreactivity for tyrosinase, HMB-45 (anti-gp100 protein), S100 protein, CD34, and vimentin was studied in 70 tumors, including 15 melanomas (5 desmoplastic, 4 amelanotic, 6 melanotic), 13 malignant peripheral nerve sheath tumors; 10 schwannomas (1 pigmented), 12 neurofibromas (4 pigmented), and 20 fibrohistiocytic tumors (10 dermatofibrosarcoma protuberans and 10 dermatofibromas). Microwave-based antigen retrieval was performed in 10mM citrate buffer, pH 6.0, for 20 minutes at 121 degrees C. RESULTS: All melanomas demonstrated positive immunostaining for tyrosinase, HMB-45, and S100 protein. Immunoreactivity for HMB-45 was generally stronger than that for tyrosinase in amelanotic lesions and significantly stronger in 1 of the desmoplastic lesions. The 4 pigmented neurofibromas were focally positive for tyrosinase, but did not stain for HMB-45. The pigmented schwannoma was focally positive for both tyrosinase and HMB-45. The malignant peripheral nerve sheath tumors, dermatofibrosarcoma protuberans, and dermatofibromas were nonreactive for tyrosinase and HMB-45. CONCLUSIONS: Our results support the sensitivity of tyrosinase expression and demonstrate the relative specificity of tyrosinase as a marker for melanocytic lesions, including desmoplastic melanoma, although pigmented peripheral nerve tumors may demonstrate focal positive staining. Immunoreactivity for tyrosinase and HMB-45 may have been enhanced by the microwave-based antigen-retrieval technique used in this study.

AB - CONTEXT: Pathologists may encounter problems in the differential diagnosis of malignant melanoma, spindle and epithelioid neoplasms of peripheral nerves, and fibrohistiocytic tumors. Tyrosinase has been demonstrated to be a sensitive marker for melanoma. OBJECTIVE: To determine the specificity of tyrosinase expression in the differential diagnosis of melanoma, desmoplastic melanoma, and peripheral nerve sheath tumors. DESIGN: Immunoreactivity for tyrosinase, HMB-45 (anti-gp100 protein), S100 protein, CD34, and vimentin was studied in 70 tumors, including 15 melanomas (5 desmoplastic, 4 amelanotic, 6 melanotic), 13 malignant peripheral nerve sheath tumors; 10 schwannomas (1 pigmented), 12 neurofibromas (4 pigmented), and 20 fibrohistiocytic tumors (10 dermatofibrosarcoma protuberans and 10 dermatofibromas). Microwave-based antigen retrieval was performed in 10mM citrate buffer, pH 6.0, for 20 minutes at 121 degrees C. RESULTS: All melanomas demonstrated positive immunostaining for tyrosinase, HMB-45, and S100 protein. Immunoreactivity for HMB-45 was generally stronger than that for tyrosinase in amelanotic lesions and significantly stronger in 1 of the desmoplastic lesions. The 4 pigmented neurofibromas were focally positive for tyrosinase, but did not stain for HMB-45. The pigmented schwannoma was focally positive for both tyrosinase and HMB-45. The malignant peripheral nerve sheath tumors, dermatofibrosarcoma protuberans, and dermatofibromas were nonreactive for tyrosinase and HMB-45. CONCLUSIONS: Our results support the sensitivity of tyrosinase expression and demonstrate the relative specificity of tyrosinase as a marker for melanocytic lesions, including desmoplastic melanoma, although pigmented peripheral nerve tumors may demonstrate focal positive staining. Immunoreactivity for tyrosinase and HMB-45 may have been enhanced by the microwave-based antigen-retrieval technique used in this study.

M3 - Journal article

C2 - 12088451

VL - 126

SP - 816

EP - 822

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 7

ER -

ID: 8466015